Alkaline Agarose Gel Electrophoresis (AAGE)

Introduction & Summary

Alkaline agarose gel electrophoresis (AAGE) is a denaturing electrophoretic method run at high pH (typically NaOH) that disrupts base-pairing so DNA migrates largely as single-stranded nucleic acid according to length. In CMC, AAGE has been widely used to assess encapsidated AAV vector genome integrity (size/truncation) after genome release, often followed by Southern blotting or fluorescent detection. By contrast, the percent supercoiled content of plasmid DNA, a common release attribute, is typically measured by neutral agarose gel electrophoresis (AGE), capillary gel electrophoresis (CGE), or anion-exchange chromatography (AEX-HPLC).

Quick Method Comparison

Method Application Sample Type Typical Run Time Sensitivity (Typical) GMP Automation Primary Use in CMC
AAGE Genome integrity / sizing AAV genomes (ssDNA after release) Hours (workflow-dependent; longer if blot/probe used) Moderate (gel-image dependent; improved with probe-based detection) Low Development, comparability, orthogonal investigations (legacy use in some programs)
CGE-LIF Genome integrity / sizing AAV genomes (ssDNA after release) Minutes (per sample; batch/queue dependent) High (platform- and method-dependent) High Routine QC / stability; commonly adopted for late-stage and commercial workflows
Neutral AGE Plasmid topology (isoforms) Plasmid DNA (dsDNA) Hours (gel + staining + imaging) Variable (densitometry- and stain-dependent) Low Early screening; supportive/legacy quantitation where justified
AEX-HPLC Plasmid topology (isoforms) Plasmid DNA (dsDNA) ~10–30 minutes (method-dependent) High (method-dependent) High GMP quantitation of % supercoiled (validated, high-throughput option)

Table 1: Comparative analytical characteristics for DNA integrity and topology assessment.

Notes:
 ssDNA = single-stranded DNA (AAV genomes post-release)
 dsDNA = double-stranded DNA (intact plasmids)
 %SC = percent supercoiled
 Sensitivity values are method- and instrument-dependent; ranges shown are typical

 

Key Quality Attributes Assessed

Method Evolution: Superseded, Current Standard, and Emerging

  • Denaturing AAGE is primarily a legacy and development-stage method for assessing AAV genome integrity. As programs mature, CGE-LIF platforms are generally adopted for routine QC due to improved analytical performance, automation, and alignment with GMP data-integrity expectations.

  • Plasmid isoform quantitation (neutral methods): Historically neutral AGE with densitometry; increasingly CGE (platform methods) and AEX-HPLC are used in GMP settings for robust, quantitative separation of supercoiled, linear, and open-circular isoforms.

Scientific Principle

At alkaline pH, DNA base-pairing is disrupted; DNA runs as single-stranded molecules whose mobility is primarily a function of length. (Other common denaturants like formamide/urea are unsuitable for agarose gels.)

Important distinction: The familiar migration order supercoiled > linear > open-circular applies to neutral agarose gels analyzing double-stranded plasmid topology. AAGE is denaturing; its readout reflects single-stranded size.

Common Instrumentation & Software

Data Output & Interpretation

AAGE (AAV): Gel image of ssDNA bands; identity/size verified against ssDNA references and/or by Southern/fluorescent probe.

Neutral AGE/CGE/AEX (plasmid): Densitometric/peak-area quantitation of supercoiled vs linear vs open-circular; report % supercoiled of total DNA.

 

Strengths

Fit-for-purpose denaturing sizing of packaged genomes; broadly used in the AAV field.

Accessible & cost-effective (basic electrophoresis hardware).

Complementary to higher-resolution CGE-LIF workflows

Limitations

  • Not topology-specific: AAGE denatures DNA and is not suitable for accurate plasmid isoform (%SC) quantitation. Use neutral AGE/CGE/AEX for that purpose.

  • Semi-quantitative unless paired with calibrated standards or blot/probe detection.

  • Throughput & manual steps can limit productivity vs automated CGE/AEX workflows.

  • Safety: NaOH handling; dyes (e.g., EtBr) have hazards.

Key Validation Considerations

  • Specificity: For AAV genome integrity, confirm band identity via probe hybridization or orthogonal sizing (CGE-LIF). For plasmid isoforms, use neutral methods with restriction/nicking controls to assign bands unambiguously.

  • Precision: Establish repeatability/intermediate precision; CGE/AEX generally provide superior precision to gel densitometry.

  • LOQ/Quantitation: Define the lowest reliably quantified minor species (e.g., truncated AAV genome fraction by AAGE+blot; minor plasmid isoforms by CGE/AEX).

  • System suitability: Pre-run criteria (resolution, ladder/size controls, acceptable background) appropriate to denaturing AAGE or to the chosen neutral method.

  • Trueness/accuracy is typically inferred via orthogonal sizing methods rather than absolute mass recovery, given the denaturing and semi-quantitative nature of gel-based readouts.

Method Standardization & Reference Materials

Regulatory expectations: FDA recommends including percent supercoiled plasmid content in plasmid release testing (historically ≥80% for DNA vaccines); gene therapy CMC guidance likewise lists % supercoiled among key purity attributes.

Reference materials: Use in-house qualified plasmid standards (with assigned isoform composition) and traceable DNA ladders.

USP has published General Chapter <1040>, Quality Considerations of Plasmid DNA as a Starting Material for Cell and Gene Therapies, and is developing a set of plasmid DNA analytical reference materials spanning multiple plasmid sizes. These materials are being characterized using orthogonal methods including CE-LIF, agarose gel electrophoresis, and anion-exchange chromatography to support plasmid topology method development and validation. At present, these materials do not assign an absolute percent supercoiled value as a certified reference standard.

Use in Specific Modalities

Plasmid DNA manufacturing: Measure % supercoiled for release/stability via neutral AGE/CGE/AEX; specification is typically justified scientifically (historically ≥80% for certain applications).

mRNA/saRNA vaccines: Residual plasmid DNA in RNA drug substance is typically controlled by qPCR/dPCR and global dsDNA assays—not by agarose gels—given sensitivity needs. USP provides materials to support these assays.

Viral vectors (AAV): AAGE (denaturing) is commonly used to assess packaged genome integrity/size distribution; CGE-LIF is an emerging higher-resolution alternative.

Key Regulatory Guidance